* NABRIVA - INFORMED BY FDA THAT, IN CONNECTION WITH REVIEW OF CONTEPO'S NDA, FDA WILL NEED TO INSPECT FACILITIES OF THIRD-PARTY MANUFACTURERS IN EUROPE * NABRIVA THERAPEUTICS - BELIEVES THERE IS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results